These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11245916)

  • 21. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.
    Maccarrone M; Valverde O; Barbaccia ML; Castañé A; Maldonado R; Ledent C; Parmentier M; Finazzi-Agrò A
    Eur J Neurosci; 2002 Apr; 15(7):1178-86. PubMed ID: 11982628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.
    Romero J; Hillard CJ; Calero M; Rábano A
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):85-93. PubMed ID: 12008024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments.
    Di Marzo V; De Petrocellis L; Bisogno T; Melck D
    Lipids; 1999; 34 Suppl():S319-25. PubMed ID: 10419192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina.
    Yazulla S; Studholme KM; McIntosh HH; Deutsch DG
    J Comp Neurol; 1999 Dec; 415(1):80-90. PubMed ID: 10540359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation.
    Prevot V; Rialas CM; Croix D; Salzet M; Dupouy JP; Poulain P; Beauvillain JC; Stefano GB
    Brain Res; 1998 Apr; 790(1-2):236-44. PubMed ID: 9593913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release.
    Stefano GB; Salzet B; Rialas CM; Pope M; Kustka A; Neenan K; Pryor S; Salzet M
    Brain Res; 1997 Jul; 763(1):63-8. PubMed ID: 9272829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence and possible biological role of the endocannabinoid system in the sea squirt Ciona intestinalis.
    Matias I; McPartland JM; Di Marzo V
    J Neurochem; 2005 Jun; 93(5):1141-56. PubMed ID: 15934935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.